Table 2.
Variable | Palpation group (n = 91) | Screening group (n = 35) | p value |
---|---|---|---|
Age (mean ± SD), years | 16 ± 3 | 17 ±2 | 0.79 |
Female, n (%) | 79 (87) | 31 (89) | 0.79 |
History of radiation, n (%) | 3 (3) | 1 (3) | 0.90 |
Histology, n (%) | – | – | 0.75 |
Papillary | 82 (90) | 33 (94) | |
Classic | 73 (80) | 29 (83) | |
Follicular | 2 (2) | 1 (3) | |
Diffuse sclerosing | 5 (6) | 3 (8) | |
Cribriform-morular | 2 (2) | 0 | |
Follicular | 7 (8) | 1 (3) | |
Medullary | 0 | 1 (3) | |
Poorly differentiated | 2 (2) | 0 | |
Median mass size, cm | 2.8 | 0.9 | <0.001 |
Mass size, n (%) | |||
<0.5 cm | 0 | 5 (14) | |
0.5 – 0.9 cm | 4 (4) | 18 (52) | |
1.0 – 1.9 cm | 15 (17) | 11 (31) | |
≥2.0 cm | 72 (79) | 1 (3) | |
T stage, n (%) | <0.001 | ||
T1 | 12 (13) | 23 (66) | |
T2 | 13 (14) | 0 | |
T3 | 32 (35) | 6 (17) | |
T4 | 34 (38) | 6 (17) | |
N stage, n (%) | |||
N0 | 23 (25) | 20 (57) | <0.001 |
N1a | 30 (33) | 11 (32) | |
N1b | 38 (42) | 4 (11) | |
Extrathyroidal extension, n (%) | |||
None | 29 (32) | 23 (66) | 0.001 |
Minimal | 28 (31) | 6 (17) | |
Gross | 34 (37) | 6 (17) | |
Distant metastasis at presentation, n (%) | 10 (11) | 0 | 0.001 |
TNM stage was described according to the 7th edition of the TNM/AJCC system.